Interlaboratory Studies Using the NISTmAb to Advance Biopharmaceutical Structural Analytics.

导出 LinkOut

翻译打印收藏纠错

第一作者： Katharina,Yandrofski

第一单位： Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology, Rockville, MD, United States.

作者： Katharina,Yandrofski ^[1] ; Trina,Mouchahoir ^[1] ; M Lorna,De Leoz ^[2] ; David,Duewer ^[3] ; Jeffrey W,Hudgens ^[1] ; Kyle W,Anderson ^[1] ; Luke,Arbogast ^[1] ; Frank,Delaglio ^[1] ; Robert G,Brinson ^[1] ; John P,Marino ^[1] ; Karen,Phinney ^[3] ; Michael,Tarlov ^[3] ; John E,Schiel ^[1]

作者单位： Institute for Bioscience and Biotechnology Research, National Institute of Standards and Technology, Rockville, MD, United States. ^[1] Agilent Technologies, Santa Clara, CA, United States. ^[2] National Institute of Standards and Technology, Gaithersburg, MD, United States. ^[3]

关键词 biopharmaceutical interlaboratory study monoclonal antibody nistmab therapeutic protein

DOI 10.3389/fmolb.2022.876780

PMID 35601836

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in molecular biosciences

2022年9卷

876780页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Interlaboratory Studies Using the NISTmAb to Advance Biopharmaceutical Structural Analytics.

Frontiers in molecular biosciences

相似文献

Frontiers in molecular biosciences

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Interlaboratory Studies Using the NISTmAb to Advance Biopharmaceutical Structural Analytics.

Frontiers in molecular biosciences

相似文献

Frontiers in molecular biosciences

相关期刊

检索历史清除